Tovorafenib Impurity 33 | CAS 1221272-92-9 - Request Quote
Tovorafenib Impurity 33
| SZ CAT No: | SZ-T202041 |
| CAS No | 1221272-92-9 |
| Mol.F. | C6H2Cl2F3N |
| Mol.Wt. | 216.0 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Tovorafenib Impurity 33 is chemically 3,5-Dichloro-4-(trifluoromethyl)pyridine. Tovorafenib Impurity 33 is supplied with detailed characterization data compliant with regulatory guideline. Tovorafenib Impurity 33 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Tovorafenib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 1221272-92-9
Purchase 1221272-92-9
Order 1221272-92-9
Enquire 1221272-92-9
price of 1221272-92-9
1221272-92-9 Supplier
1221272-92-9 Manufacturer
1221272-92-9 Exporter
buy high quality Tovorafenib Impurity 33
Purchase Tovorafenib Impurity 33
Tovorafenib Impurity 33 suppliers
Tovorafenib Impurity 33 manufacturers
Tovorafenib Impurity 33 price
Order Tovorafenib Impurity 33
Enquire Tovorafenib Impurity 33
Tovorafenib Impurity 33 cost
Tovorafenib Impurity 33 Supplier
Tovorafenib Impurity 33 Distributor
Tovorafenib Impurity 33 for Method Validation
Tovorafenib Reference Standard
Tovorafenib Impurity 33 for ANDA Filing
Tovorafenib Impurity 33 for Forced Degradation Studies
Tovorafenib Impurity 33 Identification Standards
Tovorafenib Impurity 33 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.